ST. JUDE MEDICAL - NEUROMODULATION
Manufacturer adverse-event records for ST. JUDE MEDICAL - NEUROMODULATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2010–2020 · heavy-book · typical Death-code · injury-heavy
Volume signature
ST. JUDE MEDICAL - NEUROMODULATION sits in the heavy MAUDE book
ST. JUDE MEDICAL - NEUROMODULATION accounts for 94,254 FDA MAUDE reports (#32 of 443, heavy-book tercile). Death-coded event_type share is 0.31% (typical); Injury share 90.4% (injury-heavy).
What the volume reading shows for ST. JUDE MEDICAL - NEUROMODULATION
The standout signal for ST. JUDE MEDICAL - NEUROMODULATION is filing volume: 94,254 adverse-event reports in FDA MAUDE (#32 of 443, heavy-book). Death-coded event_type share sits at 0.31% (typical).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair ST. JUDE MEDICAL - NEUROMODULATION with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Injury at 85,210 (90.4% of event_type total). Peak single-year volume reaches 13,710 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.